Global packaging scale Leverage Gerresheimer’s large global footprint and local production capabilities to position as a partner for regional launches, emphasizing nearshoring benefits, supply chain resilience, and rapid customization for pharma, biotech, and cosmetics packaging needs.

Cash preservation focus Given Q1 2026 signals of revenue growth with a emphasis on cash preservation and reduced capex, offer solutions that optimize working capital, streamline packaging and device sourcing, and provide flexible financing or longer-term procurement options.

Asset divestment opportunities With the planned sale of two packaging units to Apax and ongoing portfolio adjustments, target engagements around divestiture timelines, transition services, and reallocation of manufacturing capacity to capture efficiency gains and cross-sell digital solutions.

Digital and data capabilities Highlight Gerresheimer’s digital solutions and tech stack (Databricks, Snowflake, Kubernetes, DocuSign, etc.) as a pathway to modernize packaging programs, enable track-and-trace, serialization, and data-driven manufacturing quality improvements for pharma and cosmetics clients.

Strategic growth conversations Monitor leadership and strategic moves such as potential refinancing or debt management and any M&A activity (rejections or bids) to position products and services as essential enablers of integration, compliance, and accelerated go-to-market timelines for customers facing portfolio changes.